Characterizing Behavioral Engagement in Smartphone Cognitive Behavioral Therapy for Obsessive Compulsive Disorder: Secondary Analysis of a Randomized Controlled Trial.

```mdx

title: "Engagement Profiles in Smartphone CBT for OCD: What Usage Patterns Tell Us"

description: "A secondary analysis of a 12-week RCT finds three distinct app engagement profiles, with similar symptom improvement across groups but lower satisfaction and credibility in low users."

type: research-update

TL;DR: In a 12-week randomized trial of smartphone cognitive behavioral therapy (CBT) for obsessive compulsive disorder (OCD), users fell into three engagement profiles, and all three improved on symptom measures. Engagement intensity did not clearly predict symptom change in this small exploratory analysis, though low users rated the program less credible and less satisfying.

What the study found

Digital mental health interventions (DMHIs) are widely promoted because they can deliver evidence-based treatments at scale. Their effectiveness, however, depends on engagement, and engagement is usually measured crudely, through self-report or one or two app metrics such as login counts. This exploratory secondary analysis, published in *JMIR Formative Research*, tried to measure engagement more completely. The researchers applied a 21-variable framework based on app analytics, covering use volume, frequency, feature usage, session duration, and temporal patterns, to data from 60 adults in a 12-week randomized controlled trial of a smartphone CBT program for OCD.

Using hierarchical agglomerative cluster analysis, the team identified three engagement profiles: a high-engagement cluster (21 participants, 35%), a moderate-engagement cluster (31 participants, 52%), and a low-engagement cluster (8 participants, 13%). The clusters differed in how much and how often participants used the app, but the analysis suggests the differences were largely a matter of degree rather than fundamentally different usage styles, and the authors frame the clusters as a descriptive starting point rather than validated categories.

The central symptom finding was that all three clusters showed significant reductions in OCD severity as measured by the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). There were no statistically significant differences in Y-BOCS change across clusters. Descriptively, the high-engagement cluster had a higher proportion of treatment responders than the low-engagement cluster, but the study was not powered to confirm that difference. The authors explicitly note that the lack of significant differences may reflect limited statistical power, particularly given the small low-engagement group of eight people. The finding therefore should not be read as proof that engagement intensity is irrelevant to outcomes. It does, however, complicate simple dose-response assumptions, and it raises the possibility that more than one pattern of app use can be associated with improvement.

The subjective data point in a different direction for the low-engagement group. At baseline, the high- and moderate-engagement clusters reported similar treatment credibility and expectancy. The low-engagement cluster, however, rated the intervention as significantly less credible and held lower expectations before starting treatment. At posttreatment, that same cluster reported significantly lower satisfaction than the moderate-engagement cluster. All three clusters rated app quality as similarly high, which suggests that perceived quality of the software did not separate the groups. The authors identify pretreatment credibility and expectancy as a potentially modifiable target: if these beliefs shape who engages and how much, they may be worth addressing directly at intake.

Taken together, the findings support the feasibility of comprehensive engagement measurement across DMHIs and clinical populations, and they suggest that engagement may depend partly on patient beliefs about treatment. They do not establish that any particular engagement pattern is required for benefit, and the sample is small, exploratory, and drawn from a single trial.

What this means for you

Engagement is multidimensional. A single metric such as days logged in may miss important differences in how people use a digital program. Future research and clinical tools may benefit from measuring several dimensions at once.

Expectations matter. Users who doubted the credibility of the program at the start were more likely to disengage and less likely to be satisfied at the end. If you are starting a digital therapy, setting realistic expectations and understanding the evidence base may help you stay with it.

Low use does not automatically mean no benefit. In this study, participants with lower app use still improved on symptom measures, though the small size of that group limits confidence in the comparison.

Digital tools are supplements to care, not replacements. Anyone managing OCD should discuss treatment options with a qualified clinician. Habits that support general mental wellbeing, such as social connection and journaling, are not substitutes for evidence-based therapy.

Study details

Detail	Information
Study type	Exploratory secondary analysis of a randomized controlled trial
Population	Adults with obsessive compulsive disorder
Sample size	60
Intervention	12-week smartphone cognitive behavioral therapy
Engagement measures	21 objective app analytics variables, cluster analysis
Primary outcome	Yale-Brown Obsessive Compulsive Scale (Y-BOCS) change
Key finding	Three engagement profiles; similar symptom improvement across clusters
Limitations	Small sample, exploratory design, limited power for cluster comparisons
Journal	JMIR Formative Research
PubMed ID	42896141

Sources

1. Secondary analysis of a randomized controlled trial of smartphone cognitive behavioral therapy for obsessive compulsive disorder, *JMIR Formative Research*. PubMed. https://pubmed.ncbi.nlm.nih.gov/42896141/

```

ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.